邻近类别 圖書 [1/1] 會議論文/會議摘要 [115/179] 类别统计 近3年内发表的文件:58(17.58%) 含全文笔数:327(99.09%) 文件下载次数统计 下载大于0次:327(100.00%) 下载大于100次:313(95.72%) 全文下载总次数:138675(77.76%) 最后更新时间: 2024-12-01 12:08 上传排行 数据加载中..... 下载排行 数据加载中..... 最近上传 Pan-Asian adapted ESMO clinical pra... Nivolumab plus chemotherapy in pati... Survival of advanced/recurrent gast... Topiramate suppresses peri-infarct ... A phase 1 study of biweekly nab-pac... Plain language summary of the FOENI... Outcomes of post-immunotherapy dura... Durvalumab or placebo plus gemcitab... Impact of previous S-1 treatment on... Chromatin remodeling-related PRDM1 ...

跳至: (选择年份) 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1985 1980 1975 1970 1960 1950 (选择月份) January February March April May June July August September October November December 或输入年份:

由新到旧排序 由最旧的开始

显示项目126-150 / 330. (共14页) << < 1 2 3 4 5 6 7 8 9 10 > >> 每页显示[10|25|50]项目

日期	题名	關聯
2019-01	Pan-Asian adapted ESMO clinical practice guidelines for the management of patients with metastatic gastric cancer; a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS	Annals of Oncology. 2019 Jan;30(1):19-33.
2019-01	Pan-Asian adapted ESMO clinical practice guidelines for the management of patients with metastatic oesophageal cancer; a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS	Annals of Oncology. 2019 Jan;30(1):34-43.
2019-01	Beta-catenin-activated autocrine PDGF/Src signaling is a therapeutic target in pancreatic cancer	Theranostics. 2019 Jan;9(2):324-336.
2018-12-20	Protein arginine methyltransferase 3 enhances chemoresistance in pancreatic cancer by methylating hnRNPA1 to increase ABCG2 expression	Cancers. 2018 Dec 20;11(1):Article number 8.
2018-11-13	From friend to enemy: Dissecting the functional alteration of immunoregulatory components during pancreatic tumorigenesis	International Journal of Molecular Sciences. 2018 Nov 13;19(11):Article number 3584.
2018-11-07	Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: Expanded analysis of a global phase 3 trial	European Journal of Cancer. 2018 Nov 7;105:71-78.
2018-11	The incidence and survival of pancreatic cancer by histology, including rare subtypes: A nation-wide cancer registry-based study from Taiwan	Cancer Medicine. 2018 Nov;7(11):5775-5788.
2018-08-24	BPR1J373, a novel multitargeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumor	Cancer Science. 2018 Nov;109(11):3591-3601.
2018-07	The clinical impact of the novel tumor marker DR-70 in unresectable gastric cancer patients	Journal of the Chinese Medical Association. 2018 Jul;81(7):593-598.
2018-06	Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinoma	Annals of Oncology. 2018 Jun;29(6):1402-1408.
2018-04	The role of consolidation chemoradiotherapy in Locally Advanced Pancreatic Cancer receiving chemotherapy: An updated systematic review and meta-analysis	Cancer Research and Treatment. 2018 Apr;50(2):562-574.
2018-04	Dialysis increases the risk of bladder recurrence in patients with Upper Tract Urothelial Cancer: A population-based study	Annals of Surgical Oncology. 2018 Apr;25(4):1086-1093.
2018-03	Beau's lines in nails: An indicator of recent Docetaxel and 5-FU use	Kaohsiung Journal of Medical Sciences. 2018 Mar;34(3):181-183.
2018-03	Cure of unresectable, locally advanced pancreatic cancer after multidisciplinary therapy	Journal of Cancer Research and Practice. 2018 Mar;5(1):27-31.
2018-02-01	Myeloid-derived macrophages and secreted HSP90alpha induce pancreatic ductal adenocarcinoma development	OncoImmunology. 2018 Feb 1;7(5):Article number e1424612.
2018-01	Orchestration of H3K27 methylation: Mechanisms and therapeutic implication	Cellular and Molecular Life Sciences. 2018 Jan;75(2):209-223.
2018-01	Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer; A JSMO - ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS	Annals of Oncology. 2018 Jan;29(1):44-70.
2018-01	Phase II study of BGJ398 in patients with FGFR-altered advanced cholangiocarcinoma	Journal of Clinical Oncology. 2018 Jan;36(3):276-282.
2017-12	Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): A randomised, double-blind, placebo-controlled, phase 3 trial	Lancet. 2017 Dec;390(10111):2461-2471.
2017-10-24	Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan	Journal of the Formosan Medical Association. 2018 May;117(5):381-403.
2017-10-09	Mitochondrial phosphoenolpyruvate carboxykinase (PEPCK-M) regulates the cell metabolism of pancreatic neuroendocrine tumors (pNET) and de-sensitizes pNET to mTOR inhibitors	Oncotarget. 2017 Oct 09;8(61):103613-103625.
2017-10	Anti-angiogenic therapy in patients with advanced gastric and gastroesophageal junction cancer: A systematic review	Cancer Research and Treatment. 2017 Oct;49(4):851-868.
2017-10	First-line antibiotic therapy in Helicobacter pylori-negative low-grade gastric mucosa-associated lymphoid tissue lymphoma	Scientific Reports. 2017 Oct;7:Article number 14333.
2017-09-16	The regulatory role of aberrant Phosphatase and Tensin Homologue and Liver Kinase B1 on AKT/mTOR/c-Myc axis in pancreatic neuroendocrine tumors	Oncotarget. 2017 Sep 16;8(58):98068-98083.
2017-09	KLF10 loss in the pancreas provokes activation of SDF-1 and induces distant metastases of pancreatic ductal adenocarcinoma in the KrasG12D p53flox/flox model	Oncogene. 2017 Sep;36(39):5532-5543.

显示项目126-150 / 330. (共14页) << < 1 2 3 4 5 6 7 8 9 10 > >> 每页显示[10|25|50]项目